Central Surgical Association| Volume 128, ISSUE 4, P641-649, October 2000

Download started.


Management of biliary tract disease in heart and lung transplant patients


      Background. Preexisting gallstones and pharmacologic alterations in both bile lithogenicity and immune function may predispose organ transplant recipients to the complications of biliary calculi. Methods. Records of all 178 patients undergoing heart, lung, or heart-lung transplantation at our institution between 1980 and 1998 were reviewed. Patients with biliary tract disease were grouped as follows: group I, pretransplantation diagnosis and treatment; group II, pretransplantation diagnosis and posttransplantation treatment; group III, normal pretransplantation biliary tree with posttransplantation diagnosis and treatment; group IV, unknown pretransplantation biliary status with posttransplantation diagnosis and treatment. Comparison among groups was made with regard to ultrasound findings, presentation, indication for operation, procedure, and outcome. Results. Of the 141 patients undergoing pretransplantation and/or posttransplantation ultrasound surveillance, the prevalence of abnormal ultrasonography was 36%. All patients in group I (n = 11) underwent elective intervention without complication. Of the 14 patients (groups II through IV) undergoing posttransplantation operation, intervention was mandated by acute complications of biliary tract disease in 7. The mortality rate in these 7 patients was 29%. Conclusions. Cholecystectomy in the posttransplantation period is often required emergently and has a high mortality. Posttransplantation surveillance of the biliary tree is crucial because of the high rate of de novo stone formation. All biliary calculi should be eradicated electively in stable patients before transplantation and on diagnosis after transplantation. (Surgery 2000;128:641-9.)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Vega KJ
        • Pina I
        • Krevsky B
        Heart transplantation is associat-ed with an increased risk for pancreaticobiliary disease.
        Ann Intern Med. 1996; 124: 980-983
        • Gracie WA
        • Ransohoff DF
        The natural history of silent gall-stones.
        N Engl J Med. 1982; 307: 798-800
        • Steck TB
        • Costanzo-Nordin MR
        • Keshavarzian A
        Prevalence and management of cholelithiasis in heart transplant patients.
        J Heart Lung Transplant. 1991; 10: 1029-1032
        • Mueller XM
        • Tevaearai HT
        • Stumpe F
        • Hurni M
        • Ruchat P
        • Fischer AP
        • et al.
        Gastrointestinal disease following heart transplantation.
        World J Surg. 1999; 23: 650-656
        • Girardet RE
        • Rosenbloom P
        • DeWeese BM
        • Masri ZH
        • Attum AA
        • Barbie RN
        • et al.
        Significance of asymptomatic biliary tract disease in heart transplant recipients.
        Journal of Heart Transplantation. 1989; 8: 391-399
        • Begos DG
        • Franco KL
        • Baldwin JC
        • Lee FA
        • Revkin JH
        • Modlin IM
        Optimal timing and indications for cholecystectomy in cardiac transplant patients.
        World J Surg. 1995; 19: 661-667
        • Milas M
        • Ricketts RR
        • Amerson R
        • Kanter K
        Management of biliary tract stones in heart transplant patients.
        Ann Surg. 1996; 223: 747-756
        • Lorber MI
        • Van Buren CT
        • Flechner SM
        • Williams C
        • Kahan BD
        Hepatobiliary complications of cyclosporine therapy following renal transplantation.
        Transplant Proc. 1987; 19: 1808-1810
        • Lorber MI
        • Van Buren CT
        • Flechner SM
        • Williams C
        • Kahan BD
        Hepatobiliary and pancreatic complications of cyclosporine therapy in 466 renal transplant recipients.
        Transplantation. 1987; 43: 35-40
        • Mathisen O
        • Omland E
        • Flatmark A
        Cholestasis after cyclosporine A and glucose administration: beneficial effect of canrenoate (soldactone).
        Transplant Proc. 1988; 20: 160-161
        • Galan AI
        • Fernandez E
        • Moran D
        • Munoz ME
        • Jimenez R
        Cyclosporine A hepatotoxicity: effect of prolonged treatment with cyclosporine on biliary lipid secretion in the rat.
        Clin Exp Pharmacol Physiol. 1995; 22: 260-265
        • Bortnichak EA
        • Freeman DH
        • Ostfeld AM
        • Castelli WP
        • Kannel WB
        • Feinleib M
        • et al.
        The association between cholesterol cholelithiasis and coronary heart disease in Framingham, Massachusetts.
        Am J Epidemiol. 1985; 121: 19-28
        • Lowell JA
        • Stratta RJ
        • Taylor RJ
        • Bynon JS
        • Larsen JL
        • Nelson NL
        Cholelithiasis in pancreas and kidney transplant recipients with diabetes.
        Surgery. 1993; 114: 858-864
        • Menegaux F
        • Dorent F
        • Tabbi D
        • Pavie A
        • Chigot JP
        • Gandjbakhch I
        Biliary surgery after heart transplantation.
        Am J Surg. 1998; 175: 320-321
        • Bhatia DS
        • Bowen JC
        • Money SR
        • Van Meter CH
        • McFadden PM
        • Kot JB
        • et al.
        The incidence, morbidity, and mortality of surgical procedures after orthotopic heart transplantation.
        Ann Surg. 1997; 225: 686-694
        • Graham SM
        • Flowers JL
        • Schweitzer E
        • Bartlett ST
        • Imbembo AL
        The utility of prophylactic laparoscopic cholecystectomy in transplant candidates.
        Am J Surg. 1995; 169: 44-49
        • Sekela M
        • Hutchins DA
        • Young JB
        • Noon GP
        Biliary surgery after cardiac transplantation.
        Arch Surg. 1991; 126: 571-573
        • Peterseim DS
        • Pappas TN
        • Meyers CH
        • Shaeffer GS
        • Meyers WC
        • Van Trigt P
        Management of biliary complications after heart transplantation.
        J Heart Lung Transplant. 1995; 14: 623-631
        • Boline GB
        • Gifford RRM
        • Yang HC
        • High KM
        • Hensley FA
        • Burg JE
        • et al.
        Cholecystectomy in the potential heart transplant patient.
        J Heart Lung Transplant. 1991; 10: 269-274